These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34584239)

  • 1. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Mamez AC; Pradier A; Giannotti F; Petitpas A; Urdiola MF; Vu DL; Masouridi-Levrat S; Morin S; Dantin C; Clerc-Renaud D; Eberhardt CS; Kaiser L; Simonetta F; Chalandon Y
    Bone Marrow Transplant; 2021 Dec; 56(12):3094-3096. PubMed ID: 34584239
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
    Spyridonidis A
    Br J Haematol; 2023 Apr; 201(1):9-10. PubMed ID: 36477621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation.
    Bankova AK; Pasin C; Huang A; Cicin-Sain C; Epp S; Audige A; Mueller NJ; Nilsson J; Vilinovszki O; Nair G; Wolfensberger N; Hockl P; Schanz U; Trkola A; Kouyos R; Hasse B; Zinkernagel AS; Manz MG; Abela IA; Müller AMS
    Br J Haematol; 2023 Apr; 201(1):58-63. PubMed ID: 36382698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study.
    Ngo D; Chen J; Tinajero J; Aribi A; Arslan S; Marcucci G; Nakamura R; Al Malki MM; Forman SJ; Dadwal S; Ali H
    Stem Cell Res Ther; 2023 Apr; 14(1):95. PubMed ID: 37072867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients.
    Gavriilaki E; Papadopoulou A; Touloumenidou T; Stavridou F; Koravou EE; Giannaki M; Papalexandri A; Karavalakis G; Batsis I; Kourelis A; Chatzopoulou F; Chatzidimitriou D; Sotiropoulos D; Yannaki E; Sakellari I; Anagnostopoulos A
    Bone Marrow Transplant; 2022 Jul; 57(7):1183-1186. PubMed ID: 35449455
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.
    Takagi E; Terakura S; Fujigaki H; Okamoto A; Miyao K; Sawa M; Morishita T; Goto T; Ozawa Y; Nishida T; Fukushima N; Ozeki K; Hanajiri R; Saito K; Murata M; Tomita A; Kiyoi H
    Int J Hematol; 2023 Oct; 118(4):462-471. PubMed ID: 37561340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Pradier A; Mamez AC; Stephan C; Giannotti F; Masouridi-Levrat S; Wang S; Morin S; Neofytos D; Vu DL; Melotti A; Arm I; Eberhardt CS; Tamburini J; Kaiser L; Chalandon Y; Simonetta F
    Ann Oncol; 2022 Dec; 33(12):1333-1335. PubMed ID: 36116692
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
    Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
    J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity After Vaccination Against SARS-CoV-2 in Lung Transplant?
    López GMS; Moralejo RA; Roncal MP; Ortiz MTT; Loaiza CAQ; Rivilla AP; Gafas AP
    Transplant Proc; 2022 Nov; 54(9):2479-2481. PubMed ID: 36257877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination.
    Young JH
    Transplant Cell Ther; 2021 Sep; 27(9):700-701. PubMed ID: 34452720
    [No Abstract]   [Full Text] [Related]  

  • 11. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
    Easdale S; Shea R; Ellis L; Bazin J; Davis K; Dallas F; Thistlethwayte E; Ethell M; Potter M; Arias C; Anthias C; Nicholson E
    Transplant Cell Ther; 2021 Oct; 27(10):880.e1-880.e4. PubMed ID: 34293520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
    Einarsdottir S; Martner A; Nicklasson M; Wiktorin HG; Arabpour M; Törnell A; Vaht K; Waldenström J; Ringlander J; Bergström T; Brune M; Hellstrand K; Ljungman P; Lagging M
    Haematologica; 2022 Jun; 107(6):1479-1482. PubMed ID: 35236057
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.
    Soni M; Migliori E; Assal A; Chan HT; Ciubotariu R; Pan JB; Cicero K; Pereira M; Mapara MY; Muranski P
    Cytotherapy; 2021 Nov; 23(11):980-984. PubMed ID: 34183244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
    Thurlapati A; McGann M; Davis JA; Granger K; Roubal K; Smith D; Gaffney KJ; Cendagorta A; Herbst A; Hendrickson L; Hess BT; Hashmi H
    J Med Virol; 2023 Aug; 95(8):e29027. PubMed ID: 37548241
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and "booster" dose.
    Attolico I; Tarantini F; Carluccio P; Musto P
    Haematologica; 2022 May; 107(5):1218. PubMed ID: 35045696
    [No Abstract]   [Full Text] [Related]  

  • 18. Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
    Cao J; Liu X; Muthukumar A; Gagan J; Jones P; Zu Y
    Clin Chem; 2021 Dec; 68(1):251-253. PubMed ID: 34358295
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation.
    Mungmunpuntipantip R; Wiwanitkti V
    Transpl Infect Dis; 2022 Jun; 24(3):e13839. PubMed ID: 35419913
    [No Abstract]   [Full Text] [Related]  

  • 20. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.